Previous 10 | Next 10 |
2020 Full Year Net Revenue of $32.4 Million Up 34% vs Prior Year; Fourth Quarter Net Revenue of $9.6M Million Up 129% vs Prior Year; Provides Full Year 2021 Range of Revenues On Target to Achieve EBITDA Breakeven by 2021 Year End PARSIPPANY, NJ, March 31, 2021 (G...
Interpace Biosciences (IDXG) has entered into a definitive agreement to sell its New Haven CT CLIA certified, CAP accredited laboratory to DiamiR Biosciences.The sale is in line with previously announced restructuring and cost reduction initiatives announced by Interpace. The deal is expected...
Part of Company’s Site Consolidation and Cost Savings Measures Parsippany, NJ, March 17, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTC: IDXG) announced today that it has entered into a definitive agreement to sell its New Haven CT CLIA certified, CAP accredit...
Revenue Cycle Management Deployment Expected to Drive Cost Savings and Optimize Workflow PARSIPPANY, NJ, March 09, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc., a leader in molecular testing for cancer risk, today announced that it has expanded its relationship with ...
In-network status for ThyGeNEXT ® and ThyraMIR ® with State’s Largest Payer PARSIPPANY, NJ, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or “the Company”), today announced that Blue Cross Blue Shield ...
PARSIPPANY, NJ, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace Biosciences” or the “Company”), an emerging leader in enabling personalized medicine, today announced that on February 24, 2021, the Company satisfied the requ...
Gainers: CLPS (CLPS) +275%.Comstock Mining (LODE) +176%.TDH Holdings (PETZ) +134%.Dogness (DOGZ) +54%.Onconova Therapeutics (ONTX) +50%.EHang (EH) +42%.Processa Pharmaceuticals (PCSA) +34%.ZW Data Action Technologies (CNET) +33%.Ebang International (EBON) +22%.China Natural Resource...
Interpace Biosciences (IDXG) has lost ~31.7% so far in the pre-market trading after the company announced the impending listing from the Nasdaq.Interpace has received the notification of delisting from the exchange on February 16, 2020. Its extended period of non-compliance wit...
Interpace Biosciences (IDXG) -28% on Nasdaq delisting.Seanergy Maritime (SHIP) -23% on capital raise.KAR Auction Services (KAR) -22% on Q4 earnings.AIkido Pharma (AIKI) -20% on capital raise.Socket Mobile (SCKT) -20%.ALJ Regional (ALJJ) -17%.Immunic (IMUX)...
PARSIPPANY, NJ, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, today announced that on February 16, 2020 it had received notification from the Listing Qualif...
News, Short Squeeze, Breakout and More Instantly...
Interpace Biosciences Inc. Company Name:
IDXG Stock Symbol:
NASDAQ Market:
Interpace Biosciences Inc. Website:
PARSIPPANY, NJ, June 04, 2024 (GLOBE NEWSWIRE) -- Interpace Diagnostics ® , a subsidiary of Interpace Biosciences ® (OTCQX: IDXG), is proud to announce that new data demonstrating the application of advanced sequencing technologies in pancreatic cancer was published as an e-ab...
PARSIPPANY, NJ, May 09, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the first quarter ended March 31, 2024 and provided a business and financial update. First quarter Net ...
GD Culture Group Limited (GDC) is expected to report for Q4 2023 Citizens Inc. Class A ($1.00 Par) (CIA) is expected to report for quarter end 2023-12-31 Escalade Incorporated (ESCA) is expected to report for Q4 2023 Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31...